Sinoma Science & Technology Co.,Ltd.

SZSE:002080 Stock Report

Market Cap: CN¥22.5b

Sinoma Science & TechnologyLtd Past Earnings Performance

Past criteria checks 1/6

Sinoma Science & TechnologyLtd has been growing earnings at an average annual rate of 5.2%, while the Chemicals industry saw earnings growing at 4.9% annually. Revenues have been growing at an average rate of 12.7% per year. Sinoma Science & TechnologyLtd's return on equity is 5.5%, and it has net margins of 4.6%.

Key information

5.2%

Earnings growth rate

5.2%

EPS growth rate

Chemicals Industry Growth12.1%
Revenue growth rate12.7%
Return on equity5.5%
Net Margin4.6%
Last Earnings Update30 Sep 2024

Recent past performance updates

Sinoma Science & TechnologyLtd's (SZSE:002080) Problems Go Beyond Weak Profit

Nov 04
Sinoma Science & TechnologyLtd's (SZSE:002080) Problems Go Beyond Weak Profit

Recent updates

Is Sinoma Science & TechnologyLtd (SZSE:002080) Using Too Much Debt?

Dec 18
Is Sinoma Science & TechnologyLtd (SZSE:002080) Using Too Much Debt?

Sinoma Science & TechnologyLtd's (SZSE:002080) Problems Go Beyond Weak Profit

Nov 04
Sinoma Science & TechnologyLtd's (SZSE:002080) Problems Go Beyond Weak Profit

Even With A 44% Surge, Cautious Investors Are Not Rewarding Sinoma Science & Technology Co.,Ltd.'s (SZSE:002080) Performance Completely

Oct 08
Even With A 44% Surge, Cautious Investors Are Not Rewarding Sinoma Science & Technology Co.,Ltd.'s (SZSE:002080) Performance Completely

Should You Investigate Sinoma Science & Technology Co.,Ltd. (SZSE:002080) At CN¥9.99?

Sep 25
Should You Investigate Sinoma Science & Technology Co.,Ltd. (SZSE:002080) At CN¥9.99?

Estimating The Fair Value Of Sinoma Science & Technology Co.,Ltd. (SZSE:002080)

Sep 10
Estimating The Fair Value Of Sinoma Science & Technology Co.,Ltd. (SZSE:002080)

Bearish: Analysts Just Cut Their Sinoma Science & Technology Co.,Ltd. (SZSE:002080) Revenue and EPS estimates

Aug 26
Bearish: Analysts Just Cut Their Sinoma Science & Technology Co.,Ltd. (SZSE:002080) Revenue and EPS estimates

Sinoma Science & TechnologyLtd (SZSE:002080) Might Be Having Difficulty Using Its Capital Effectively

Aug 21
Sinoma Science & TechnologyLtd (SZSE:002080) Might Be Having Difficulty Using Its Capital Effectively

These 4 Measures Indicate That Sinoma Science & TechnologyLtd (SZSE:002080) Is Using Debt Extensively

Jul 25
These 4 Measures Indicate That Sinoma Science & TechnologyLtd (SZSE:002080) Is Using Debt Extensively

Why Sinoma Science & Technology Co.,Ltd. (SZSE:002080) Could Be Worth Watching

Jun 10
Why Sinoma Science & Technology Co.,Ltd. (SZSE:002080) Could Be Worth Watching

Sinoma Science & TechnologyLtd (SZSE:002080) Has Announced That Its Dividend Will Be Reduced To CN¥0.56

May 27
Sinoma Science & TechnologyLtd (SZSE:002080) Has Announced That Its Dividend Will Be Reduced To CN¥0.56

Capital Allocation Trends At Sinoma Science & TechnologyLtd (SZSE:002080) Aren't Ideal

May 13
Capital Allocation Trends At Sinoma Science & TechnologyLtd (SZSE:002080) Aren't Ideal

Are Sinoma Science & Technology Co.,Ltd. (SZSE:002080) Investors Paying Above The Intrinsic Value?

Apr 14
Are Sinoma Science & Technology Co.,Ltd. (SZSE:002080) Investors Paying Above The Intrinsic Value?

Earnings Troubles May Signal Larger Issues for Sinoma Science & TechnologyLtd (SZSE:002080) Shareholders

Mar 31
Earnings Troubles May Signal Larger Issues for Sinoma Science & TechnologyLtd (SZSE:002080) Shareholders

Sinoma Science & Technology Co.,Ltd.'s (SZSE:002080) Price Is Right But Growth Is Lacking

Mar 14
Sinoma Science & Technology Co.,Ltd.'s (SZSE:002080) Price Is Right But Growth Is Lacking

Should You Think About Buying Sinoma Science & Technology Co.,Ltd. (SZSE:002080) Now?

Feb 28
Should You Think About Buying Sinoma Science & Technology Co.,Ltd. (SZSE:002080) Now?

Revenue & Expenses Breakdown

How Sinoma Science & TechnologyLtd makes and spends money. Based on latest reported earnings, on an LTM basis.

Earnings and Revenue History

SZSE:002080 Revenue, expenses and earnings (CNY Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Sep 2424,3881,1261,8831,253
30 Jun 2424,0501,2981,8291,293
31 Mar 2425,2762,0271,8081,242
31 Dec 2325,8892,2241,8021,299
30 Sep 2326,3172,8361,6841,323
30 Jun 2326,7573,0791,6571,264
31 Mar 2326,1963,2531,5781,262
01 Jan 2325,8143,5741,5031,209
30 Sep 2223,4623,1721,5071,060
30 Jun 2222,3723,4131,381988
31 Mar 2220,9343,5181,286940
31 Dec 2120,2953,3731,260961
30 Sep 2120,5223,1591,1871,065
30 Jun 2120,6002,9771,1981,113
31 Mar 2119,9992,3871,2321,075
31 Dec 2018,8652,0401,189973
30 Sep 2017,0381,889785850
30 Jun 2015,1481,634870653
31 Mar 2013,8211,405863552
31 Dec 1913,5901,380968515
30 Sep 1913,1481,1671,353358
30 Jun 1912,7321,1651,213358
31 Mar 1911,9859621,212357
31 Dec 1811,4118941,151356
30 Sep 1810,8079131,082392
30 Jun 1810,504778961540
31 Mar 1810,2897781,032439
31 Dec 1710,2377671,086348
30 Sep 179,6956991,166222
30 Jun 179,3865391,4410
31 Mar 179,2054991,3550
31 Dec 168,7004381,3380
30 Sep 168,7854361,3370
30 Jun 168,8135681,3310
31 Mar 169,7286781,3860
31 Dec 159,1766301,2470
30 Sep 158,2166131,0250
30 Jun 156,9894518260
31 Mar 154,8371946650
31 Dec 144,4241526490
30 Sep 143,9811086220
30 Jun 143,680925930
31 Mar 143,545965820
31 Dec 133,4431085670

Quality Earnings: 002080 has a large one-off gain of CN¥1.0B impacting its last 12 months of financial results to 30th September, 2024.

Growing Profit Margin: 002080's current net profit margins (4.6%) are lower than last year (10.8%).

Free Cash Flow vs Earnings Analysis

Past Earnings Growth Analysis

Earnings Trend: 002080's earnings have grown by 5.2% per year over the past 5 years.

Accelerating Growth: 002080's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.

Earnings vs Industry: 002080 had negative earnings growth (-60.3%) over the past year, making it difficult to compare to the Chemicals industry average (-4.7%).

Return on Equity

High ROE: 002080's Return on Equity (5.5%) is considered low.

Return on Assets

Return on Capital Employed

Discover strong past performing companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/18 00:45
End of Day Share Price 2024/12/18 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Sinoma Science & Technology Co.,Ltd. is covered by 24 analysts. 10 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Aaron HoCFRA Equity Research
Chao FanChangjiang Securities Co. LTD.
Ce ZhouChasing Securities